Biktarvy, formally known as biktarvy, includes a powerful single-tablet regimen for controlling HIV infection. This formula unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to multiply within the body, considerably lowering the viral quantity. For many individu